Friday, March 29, 2024
HomeTagsRivus Pharmaceuticals

Rivus Pharmaceuticals

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics